1

Your cart is empty.

The Most-Trusted Regulations & Guidelines Books on the Market.

Celebrating 15 Years of Excellence.

Now Shipping April 2017 Books

Book M2:  2017 Mini Pocket-Sized (3" x 5") Code of Federal Regulations on Good Clinical Practice, 21 CFR Parts 11, 50, 54, 56, 312 (Does not include Part 314 or any ICH Guidelines)

Book M2: 2017 Mini Pocket-Sized (3" x 5") Code of Federal Regulations on Good Clinical Practice, 21 CFR Parts 11, 50, 54, 56, 312 (Does not include Part 314 or any ICH Guidelines)

$ 10.95

Return to Previous Page

This spiral-bound, 3" x 5" book contains the key US regulations governing the conduct of clinical studies for FDA approval. It also includes a detailed subject index for quick and convenient access to information. NOTE: It does not contain 21 CFR Part 314 or any ICH guidelines or FDA guidance documents. Users requiring ICH guidelines and FDA guidance documents should browse through the other books listed under the heading, "Clinical Research and Good Clinical Practice" on this website.

Books are pocket-sized with a tiny coil binding for easy transportability. Sections have printed section dividers for easy navigation between topics.

Who Uses this Book and How?
• Clinical Research staff, as job aids
• Training departments, as training handouts
• Human Resources, as part of new-employee orientation
• Legal/Regulatory/QA staff, for company-wide distribution

What's the Price?
• 1-249 copies:  $10.95             • 250-499 copies:  $9.95
• 500-749 copies: $8.95          • 750+ copies:  $7.95

Custom Cover Prices*?
• 1-24 copies:  unavailable             • 25-100 copies:  $2.00/book
• 100-249 copies: $1.00/book        • 250+ copies:  No charge

* Based on quantities of a single book title

    54, 56, & 312

• CFR Title 21:  Food and Drugs (Revised as of April 1, 2017)
       Parts  11    Electronic Records/Electronic Signatures (Revised 2017)
                 50    Protection of Human Subjects
                 54    Financial Disclosure
                 56    Institutional Review Boards (Revised 2017)
                 312  Investigational New Drug Application

Click here to see an enlarged pdf cover